Detalles de la búsqueda
1.
Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects.
Antimicrob Agents Chemother;
60(10): 5849-57, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27431215
2.
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections.
Antimicrob Agents Chemother;
59(1): 372-80, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25367904
3.
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae.
Antimicrob Agents Chemother;
58(2): 885-91, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24277021
4.
Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System.
Am J Health Syst Pharm;
2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365226
5.
Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.
Antimicrob Agents Chemother;
57(4): 1777-83, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357764
6.
Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects.
Antimicrob Agents Chemother;
57(3): 1496-504, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23295928
7.
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia.
Antimicrob Agents Chemother;
57(12): 6348-50, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041902
8.
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients.
Pediatr Infect Dis J;
42(2): 99-105, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638392
9.
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections.
Pediatr Infect Dis J;
42(3): 199-205, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476623
10.
Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.
Clin Pharmacol Drug Dev;
10(4): 420-427, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33465279
11.
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
J Antimicrob Chemother;
65 Suppl 4: iv9-16, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21115457
12.
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.
J Clin Pharmacol;
57(3): 345-355, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27510635
13.
Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
Expert Rev Clin Pharmacol;
8(6): 691-707, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26420166
14.
Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
J Nucl Med;
44(3): 422-33, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12621010
15.
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.
AAPS PharmSci;
4(2): E8, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12102617
16.
Albugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys.
Pharm Res;
19(11): 1720-9, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12458679
Resultados
1 -
16
de 16
1
Próxima >
>>